---
title: "CICC Sticks to Their Buy Rating for CSPC Pharmaceutical Group (CHJTF)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288013817.md"
description: "CICC has reaffirmed its Buy rating for CSPC Pharmaceutical Group (CHJTF) with a price target of HK$12.00, while the stock closed at HK$6.96. The average analyst consensus rating is Moderate Buy with a target of HK$10.42, indicating a potential 49.70% upside. CMB International Securities also maintains a Buy rating with a target of HK$13.05."
datetime: "2026-05-29T05:18:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288013817.md)
  - [en](https://longbridge.com/en/news/288013817.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288013817.md)
---

# CICC Sticks to Their Buy Rating for CSPC Pharmaceutical Group (CHJTF)

CICC analyst maintained a Buy rating on CSPC Pharmaceutical Group yesterday and set a price target of HK$12.00. The company’s shares closed last Friday at HK$6.96.

### Memorial Day Sale – Claim 70% Off TipRanks

-   Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
-   Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for CSPC Pharmaceutical Group with a HK$10.42 average price target, implying a 49.70% upside from current levels. In a report released yesterday, CMB International Securities also maintained a Buy rating on the stock with a HK$13.05 price target.

### Related Stocks

- [01093.HK](https://longbridge.com/en/quote/01093.HK.md)
- [03908.HK](https://longbridge.com/en/quote/03908.HK.md)
- [601995.CN](https://longbridge.com/en/quote/601995.CN.md)

## Related News & Research

- [TD Cowen Sticks to Its Buy Rating for e.l.f. Beauty (ELF)](https://longbridge.com/en/news/287708987.md)
- [CICC Sticks to Its Buy Rating for CSPC Pharmaceutical Group (CHJTF)](https://longbridge.com/en/news/274393834.md)
- [Barclays Keeps Their Buy Rating on Compagnie Financiere Richemont SA (CFR)](https://longbridge.com/en/news/287715923.md)
- [Jefferies Sticks to Their Sell Rating for CSPC Pharmaceutical Group (CHJTF)](https://longbridge.com/en/news/280592047.md)
- [TD Cowen Reaffirms Their Buy Rating on Kailera Therapeutics, Inc. (KLRA)](https://longbridge.com/en/news/287719655.md)